DK3639829T3 - Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel - Google Patents

Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel Download PDF

Info

Publication number
DK3639829T3
DK3639829T3 DK18827765.1T DK18827765T DK3639829T3 DK 3639829 T3 DK3639829 T3 DK 3639829T3 DK 18827765 T DK18827765 T DK 18827765T DK 3639829 T3 DK3639829 T3 DK 3639829T3
Authority
DK
Denmark
Prior art keywords
medicines
tumors
prevention
iii
manufacture
Prior art date
Application number
DK18827765.1T
Other languages
English (en)
Inventor
Enhong Jiang
Weinqing He
Jianlu Dai
Yang Jiang
Xulein Jiang
Xiaofeng Zhao
Original Assignee
Shenyang Fuyang Pharmaceutical Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Tech Co Ltd filed Critical Shenyang Fuyang Pharmaceutical Tech Co Ltd
Application granted granted Critical
Publication of DK3639829T3 publication Critical patent/DK3639829T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK18827765.1T 2017-07-04 2018-07-04 Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel DK3639829T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201710537958 2017-07-04
CN201711497546 2017-12-27
CN201711450396 2017-12-27
CN201711450300 2017-12-27
PCT/CN2018/094504 WO2019007368A1 (zh) 2017-07-04 2018-07-04 异戊酰螺旋霉素i、ii和/或iii在制备治疗和/或预防肿瘤药物方面的应用和药物

Publications (1)

Publication Number Publication Date
DK3639829T3 true DK3639829T3 (da) 2022-05-16

Family

ID=64950608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18827765.1T DK3639829T3 (da) 2017-07-04 2018-07-04 Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel

Country Status (12)

Country Link
US (1) US20200163984A1 (da)
EP (1) EP3639829B1 (da)
JP (1) JP7060631B2 (da)
KR (1) KR102375444B1 (da)
CN (1) CN110869027B (da)
AU (1) AU2018298187A1 (da)
CA (1) CA3068921A1 (da)
DK (1) DK3639829T3 (da)
ES (1) ES2912734T3 (da)
MX (1) MX390755B (da)
RU (1) RU2766176C2 (da)
WO (1) WO2019007368A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110051845A (zh) * 2018-01-19 2019-07-26 沈阳福洋医药科技有限公司 一种mTOR抑制剂、药物组合物及其应用
MX2020007627A (es) 2018-01-19 2020-11-24 Shenyang Fuyang Pharmaceutical Tech Co Ltd Uso de la carrimicina o de sus ingredientes activos.
KR20220008895A (ko) * 2019-05-16 2022-01-21 쉔양 푸양 파마슈티컬 테크놀로지 컴퍼니 리미티드 섬유증을 예방, 완화 및/또는 치료하는 약물, 복합 제품 및 이의 응용
US11351185B2 (en) 2020-03-11 2022-06-07 Asclea Corporation Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis
CN113577086B (zh) * 2020-04-30 2023-05-02 沈阳福洋医药科技有限公司 异戊酰螺旋霉素类化合物或其组合物在制备治疗免疫失调的药物中的应用
CN113372397A (zh) * 2021-06-22 2021-09-10 天方药业有限公司 一种己二酸螺旋霉素的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1540397A (en) * 1976-12-08 1979-02-14 May & Baker Ltd Spiramycin esters
CA2127578A1 (en) * 1993-07-08 1995-01-09 Keiichi Ajito 16-membered macrolide derivatives and process for producing the same
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
DE602007006663D1 (de) 2006-06-12 2010-07-01 Univ Ramot Verfahren zur behandlung von krebs
CN101362784A (zh) 2008-10-06 2009-02-11 山东大学 埃博霉素苷类化合物和以其为活性成分的组合物及其应用
CN101785779B (zh) 2010-03-09 2014-03-05 沈阳同联集团有限公司 异戊酰螺旋霉素ii的分离制备
CN101785778A (zh) * 2010-03-09 2010-07-28 沈阳同联集团有限公司 异戊酰螺旋霉素i的分离制备及其应用
CN101773510B (zh) 2010-03-09 2013-06-05 沈阳同联集团有限公司 异戊酰螺旋霉素iii的分离制备
CA2800019C (en) 2010-05-25 2015-05-26 Shenyang Tonglian Group Co., Ltd. Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
CN102229634B (zh) * 2010-05-25 2014-05-28 沈阳同联集团有限公司 左旋异戊酰螺旋霉素i、其制剂、制备方法及应用
EP2578595B1 (en) * 2010-05-25 2017-04-19 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Crystalline levoisovalerylspiramycin i
RU2746047C1 (ru) * 2017-04-06 2021-04-06 Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. Применение карримицина и его фармацевтически приемлемой соли для производства медикаментов для лечения и/или профилактики опухоли

Also Published As

Publication number Publication date
KR102375444B1 (ko) 2022-03-17
JP2020528047A (ja) 2020-09-17
EP3639829B1 (en) 2022-02-09
US20200163984A1 (en) 2020-05-28
KR20200024280A (ko) 2020-03-06
RU2020102713A (ru) 2021-08-04
CN110869027A (zh) 2020-03-06
EP3639829A1 (en) 2020-04-22
MX390755B (es) 2025-03-21
RU2766176C2 (ru) 2022-02-08
ES2912734T3 (es) 2022-05-27
RU2020102713A3 (da) 2021-08-04
CN110869027B (zh) 2023-09-08
EP3639829A4 (en) 2020-06-24
JP7060631B2 (ja) 2022-04-26
CA3068921A1 (en) 2019-01-10
AU2018298187A1 (en) 2020-02-06
WO2019007368A1 (zh) 2019-01-10
MX2019015676A (es) 2022-03-17

Similar Documents

Publication Publication Date Title
DK3639829T3 (da) Anvendelse af isovalerylspiramycin i eller iii ved fremstilling af lægemiddel til behandling og/eller forebyggelse af tumor samt lægemiddel
IL269150A (en) Compositions and methods for treating cancer
IL263224A (en) Methods and compositions for treating cancers
IL272470A (en) Methods and materials for assessing and treating cancer
IL258955A (en) Compositions and methods for treatment of cancer
IL268814A (en) Compositions and methods for treatment of cancer
EP3471735A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
HUE054548T2 (hu) Amino-triazolopiridin vegyületek és azok alkalmazása rák kezelésében
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
DK3600281T3 (da) Kombinationsbehandling til behandling eller forebyggelse af tumorer
EP3565558A4 (en) POLYTHERAPY FOR CANCER TREATMENT
IL269157A (en) Compositions and methods for treating cancer
DK3153169T3 (da) Fremgangsmåde til behandling af tumor, farmaceutisk sammensætning og medicinæskesæt
IL258259A (en) Adjunctive therapy with 25-hydroxyvitamin d and articles therefor
EP3212228C0 (en) MARAVIROC ALONE OR IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER
IL266623A (en) A pharmaceutical preparation for use in the therapeutic treatment of cancer and complications of cancer
IL266486A (en) Pharmaceutical preparations and methods for cancer treatment
HUE053927T2 (hu) Farneziltranszferáz inhibitorok rák kezelésében történõ alkalmazásra
EP3862000C0 (en) CHRONIC COUGH TREATMENT MEDICATION
IL253582B (en) Detection and treatment of malignant tumours in the cns
EP3290034A4 (en) Use of trimethazine in preparation of drugs for preventing and treating liver diseases
IL280587B (en) Fluorocitidine derivatives and their preparations for use in cancer treatment
EP3556402A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEPATITIS B
IL264407A (en) Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases
EP3708173C0 (en) PHARMACEUTICAL COMPOSITION COMPRISING MIRNA-3140 FOR THE TREATMENT OF CANCER